- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ATL adds Doppler enhancement to HDI
ATL of Bothell, WA, last month introduced Doppler power imaging,an enhancement to its Ultramark 9 high-definition imaging (HDI)scanner that allows clinicians to visualize flow in small vessels.Doppler power imaging gives clinicians real-time color
ATL of Bothell, WA, last month introduced Doppler power imaging,an enhancement to its Ultramark 9 high-definition imaging (HDI)scanner that allows clinicians to visualize flow in small vessels.Doppler power imaging gives clinicians real-time color displayof blood flow in the vascular beds of certain tissues. Potentialapplications include evaluation of native and transplanted kidneys,tumors and testicular and ovarian tissue.
The vendor will begin shipping Doppler power imaging on HDIsystems this fall at no additional charge to customers. This featurewill be made available for all existing HDI systems in January.
In other ATL news, the vendor is sponsoring a study at 10 clinicalsites in the U.S., Canada and Europe to determine the effectivenessof ultrasound in characterizing breast tumors.
In the study, clinicians are evaluating whether sonographersusing HDI scanners can differentiate malignant from nonmalignantbreast lesions. HDI's ability to image a small tumor's structuralcharacteristics and vascularity could help physicians determinewhether an abnormality is malignant, according to the company.
If the study proves successful, ultrasound could in some casesreplace a surgical procedure with an ultrasound examination. ATL'sgoal is to eliminate one-third of surgical breast biopsies, accordingto the company.
BRIEFLY NOTED:
- The ultrasound market continues to sag. Both Acuson andDiasonics reported drops in revenue last week. Acuson's declinewas the sharpest, from $84.5 million in sales during the thirdquarter of 1992 (end-September) to $67 million in the same periodthis year. Acuson's third quarter net income dropped from $7 millionlast year to $2.3 million in 1993.
Diasonics Ultrasound, now an independent, single-modality company,saw revenue drop from $50.3 million in the third quarter of 1992to $46.2 million in the same period of this year. The ultrasoundvendor continues to lose money, but at a significantly lower rate.Diasonics lost $1.9 million in the third quarter of this year,compared to $4.4 million in the same period of 1992.
"Given the ongoing weakness of the ultrasound market,we are pleased that we have been able to maintain revenue levelsduring 1993," said Diasonics Ultrasound CFO Shawn O'Connor.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
